Skip to content

Ability of Patients With Low Vision to Properly Instill Eye Drops

Objective Evaluation of the Ability of Patients With Decreased Vision or Restricted Visual Fields to Properly Instill Eye Drops

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00760240
Enrollment
200
Registered
2008-09-26
Start date
2008-09-30
Completion date
2009-09-30
Last updated
2010-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Retinal Pathology

Keywords

compliance, eyedrop instillation, How patients with low vision due to glaucoma or retinal pathology instill eyedrops into their own eyes.

Brief summary

The investigators are interested in seeing how people with low vision (decreased visual acuity or restricted visual fields) instill eye drops into their own eyes. The investigators hypothesis is that this population will have more difficulty with self-instillation of drops than a better-seeing population. The investigators aim to explore whatever factors may be involved in preventing this population from getting prescribed eyedrops into their eyes, whether it is more related to visual field or visual acuity.

Detailed description

This is a study that involves a questionnaire that a study participant fills out, detailing their experience with eyedrops (if any), followed by a video recording of them instilling artificial tears into their worse-seeing eye, with their dominant hand. Patients must have visual acuity worse than 20/60 in at least one eye, and/or have a recent visual field that demonstrated Hodapp criteria for Moderate or Severe visual field damage. This is an observational study of how patients with low vision due to either glaucoma or retinal disease instill eyedrops. Each video will be graded by the principal investigator for success at instilling eyedrops, and patients will be stratified by their visual acuity or visual field, and whether they have a primary diagnosis of glaucoma or retinal disease.

Interventions

None listed

Sponsors

Mid-Atlantic Glaucoma Experts
Lead SponsorOTHER

Study design

Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* ETDRS visual acuity 20/60 or worse

Exclusion criteria

* Unwilling to participate * Light perception vision * No light perception vision

Design outcomes

Primary

MeasureTime frame
Successful instillation of a single eyedrop onto the surface of the eye2 minutes

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026